Jorgensen became CEO in January 2017 and the company’s market capitalization has more than tripled during his tenure. Novo was first to market with Wegovy and its sister drug Ozempic for diabetes, but ...

Novo Nordisk said Jørgensen will remain in his role temporarily to ensure a “smooth transition” while a search for his ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

"Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that ...

A daily pill could give patients the weight-loss benefits of gastric bypass surgery or drugs like Ozempic without the negative side effects, according to a new study. Dr. Jessica Duncan, a ...

U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Danish pharmaceutical giant Novo Nordisk is saying goodbye to its chief executive amid growing competition for its ...

Demand has soared for treatments targeting the less alluring effects of getting skinny quick. Make your appointment, stat!

Ozempic was approved to treat Type 2 diabetes in 2017, and it’s become increasingly popular among those who don’t have the ...

Sharon Osbourne triggered fears she was 'wasting away' after being spotted looking 'thinner than ever' during a recent shopping trip ...

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...